- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Addressing Health Care Access Gaps With Digital Solutions
On this episode of Managed Care Cast, Sarah Carroll, MPH, director of the Center for Care Transformation at AVIA, discusses the challenges of implementing digital health in underserved populations and the potential of these solutions to better address health disparities in the United States.
The COVID-19 pandemic has brought disparities in health care to the forefront of the national conversation and simultaneously jump-started widespread use of telehealth and digital solutions to address newly formed health care access gaps.
But even before the pandemic began, the Center for Care Transformation at AVIA was helping members move from reactive, episodic, and uncoordinated care to proactive, longitudinal, and efficient care.
AVIA, a network of 50 leading health systems brought together in a collaborative membership model, offers a range of digital solutions to drive clinical, operational and financial results.
On this episode of Managed Care Cast, we speak with Sarah Carroll, MPH, director of the Center for Care Transformation at AVIA, about the challenges of implementing digital health in underserved populations and the potential of these solutions to better address health disparities in the United States.
Listen above or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More
